colorectal cancer

Tumor Location an Influencer of Survival in Patients With Colorectal Cancer
06/04/2016
JCP Editors
The physical location of a primary tumor may be an indicator of survivor in patients with metastatic colorectal cancer (mCRC), according to results from a large retrospective study presented at the American Society...
The physical location of a primary tumor may be an indicator of survivor in patients with metastatic colorectal cancer (mCRC), according to results from a large retrospective study presented at the American Society...
The...
06/04/2016
Journal of Clinical Pathways
Research in Review
Biomarkers Predict Cetuximab Performance in Metastatic Colorectal Cancer
05/17/2016
JCP Editors
Treatment with cetuximab is most effective for patients with KRAS wild-type colorectal cancers carrying a specific genetic marker, according to a recent study. In an article published in Clinical Cancer Research,...
Treatment with cetuximab is most effective for patients with KRAS wild-type colorectal cancers carrying a specific genetic marker, according to a recent study. In an article published in Clinical Cancer Research,...
...
05/17/2016
Journal of Clinical Pathways
Research in Review
Breast Cancer Drug Shows Benefit in HER2-Positive Colorectal Cancer
05/05/2016
JCP Editors
Patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic colorectal cancer may benefit from a targeted therapy regimen used to treat HER2-positive breast cancer with no need for added...
Patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic colorectal cancer may benefit from a targeted therapy regimen used to treat HER2-positive breast cancer with no need for added...
...
05/05/2016
Journal of Clinical Pathways
Oncology Nurse Navigators Improve GI Cancer Outcomes
04/28/2016
JCP Editors
At the second annual Oncology Nurse Advisor Navigation Summit (April 7-9, 2016; Orlando, FL), Teresa Labovich, MSN, RN, OCN, Penrose Cancer Center (Colorado Springs, CO), described a method by which gastrointestinal...
At the second annual Oncology Nurse Advisor Navigation Summit (April 7-9, 2016; Orlando, FL), Teresa Labovich, MSN, RN, OCN, Penrose Cancer Center (Colorado Springs, CO), described a method by which gastrointestinal...
At the...
04/28/2016
Journal of Clinical Pathways
Research in Review
Multiple-Treatment Regimens for Colorectal Cancer Have High Costs and Little Benefit to Elderly Patients
03/02/2016
JCP Editors
A 10-year study has found that the rate of elderly patients receiving 3 or more treatments for metastatic colorectal cancer has increased substantially from 2000 to 2009, but that added agents may not lead to...
A 10-year study has found that the rate of elderly patients receiving 3 or more treatments for metastatic colorectal cancer has increased substantially from 2000 to 2009, but that added agents may not lead to...
A...
03/02/2016
Journal of Clinical Pathways
Research in Review
Predictive Biomarker for Panitumumab Therapy Effectiveness in Patients With Colorectal Cancer
02/12/2016
JCP Editors
Expression of epidermal growth factor receptor ligands epiregulin (EREG) and amphiregulin (AREG) may help determine which patients with colorectal cancer are the most likely to benefit from panitumumab therapy. The...
Expression of epidermal growth factor receptor ligands epiregulin (EREG) and amphiregulin (AREG) may help determine which patients with colorectal cancer are the most likely to benefit from panitumumab therapy. The...
...
02/12/2016
Journal of Clinical Pathways
Clinical Insights
SIRFLOX Data Show Mixed Results for Survival
08/05/2015
The landmark SIRFLOX trial, a randomized controlled trial of SIR-Spheres Y90 microspheres (Sirtex) in patients with metastatic colorectal cancer (mCRC), has shown evidence suggesting that a first-line treatment strategy of standard of care...
The landmark SIRFLOX trial, a randomized controlled trial of SIR-Spheres Y90 microspheres (Sirtex) in patients with metastatic colorectal cancer (mCRC), has shown evidence suggesting that a first-line treatment strategy of standard of care...
The landmark SIRFLOX trial, a...
08/05/2015
IO Learning
News
New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer
08/03/2015
Adding SIR-Spheres® Y-90 resin microspheres to first-line chemotherapy for patients with unresectable metastatic colorectal cancer in the liver (mCRC) further extends Progression-Free Survival in that organBarcelona, Spain (4 July...
Adding SIR-Spheres® Y-90 resin microspheres to first-line chemotherapy for patients with unresectable metastatic colorectal cancer in the liver (mCRC) further extends Progression-Free Survival in that organBarcelona, Spain (4 July...
Adding SIR-Spheres® Y-90 resin...
08/03/2015
IO Learning
Clinical Insights
Andor van den Hoven, MD, Describes a Particle-Fluid Dynamics Study for Radioembolization of Colorectal Liver Metastases
07/28/2015
IO360: Please describe your facility, the makeup of the IO team, and the IO procedures done at your facility.van den Hoven: I am an MD working as a PhD candidate at the Department of Radiology and Nuclear Medicine of the University Medical...
IO360: Please describe your facility, the makeup of the IO team, and the IO procedures done at your facility.van den Hoven: I am an MD working as a PhD candidate at the Department of Radiology and Nuclear Medicine of the University Medical...
IO360: Please describe your...
07/28/2015
IO Learning
Clinical Insights
Management of Locoregional Recurrence of Rectal Cancer After Surgery Using Radiofrequency Ablation
07/17/2015
Abstract: The primary mode of treatment for rectal carcinoma is resection. Despite radical surgery, 10% to 25% of patients develop local recurrence, the majority of which involve pelvic sidewall or surrounding organs. Radiofrequency ablation...
Abstract: The primary mode of treatment for rectal carcinoma is resection. Despite radical surgery, 10% to 25% of patients develop local recurrence, the majority of which involve pelvic sidewall or surrounding organs. Radiofrequency ablation...
Abstract: The primary mode of...
07/17/2015
IO Learning

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use